Simpson Thacher, acting as sole international counsel, represented Société Générale, as arranger and dealer, and BNP Paribas, Citigroup Global Markets Inc., Commerzbank Aktiengesellschaft, Crédit Agricole Corporate...
You must be a Standard 1 Year member to access this content.
Simpson Thacher represented Yunfeng Capital in connection with the formation of Yunfeng Fund III, its third Greater China-focused private equity fund. The fund focuses primarily on...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the underwriters and the joint global coordinators in the public offering of BeiGene, Ltd. on the Hong Kong Stock Exchange. The gross proceeds...
You must be a Standard 1 Year member to access this content.
Barclays and EY are acting as REEL and KKR’s M&A advisors, respectively. Link Legal serves as REEL’s legal counsel, and PwC and Transaction Square act as...
You must be a Standard 1 Year member to access this content.
Davis Polk is advising Heineken N.V. in connection with its non-binding agreements with China Resources Enterprise (“CRE”) and China Resources Beer (Holdings) Co. Ltd. (“CR Beer”)...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Vanke Service (HongKong) Co., a subsidiary of China Vanke, on its subscription for 4.9% of the ordinary shares of Cushman & Wakefield plc...
You must be a Standard 1 Year member to access this content.
Simpson Thacher represented the underwriters including, Goldman Sachs (Asia) L.L.C. and Credit Suisse, in connection with the initial public offering and listing on the NASDAQ Global...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Hope Education Group Co., Ltd. in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international...
You must be a Standard 1 Year member to access this content.
Simpson Thacher represented the underwriters in the initial public offering and Regulation S offering by Fusen Pharmaceutical Company Limited (“Fusen Pharmaceutical”). Fusen Pharmaceutical offered an aggregate...
You must be a Standard 1 Year member to access this content.
Simpson Thacher is acting as lead counsel to a consortium led by KKR to acquire all of the issued and outstanding shares of LCY Chemical Corp....
You must be a Standard 1 Year member to access this content.
Simpson Thacher represented the underwriters in the initial public offering in Hong Kong and Rule 144A/Regulation S offering by Qeeka Home (Cayman) Inc. (“Qeeka Home”). Qeeka...
You must be a Standard 1 Year member to access this content.
Simpson Thacher advised SK Holdings in connection with its announced agreement to acquire AMPAC Fine Chemicals (“AFC”), a leading contract development and manufacturing organization (“CDMO”). Financial...
You must be a Standard 1 Year member to access this content.
